A clinical trial to study the effect of the drug Dexmedetomidine in controlling agitation which occurs after general anesthesia in oral and nasal surgeries
Phase 3
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2021/12/038949
- Lead Sponsor
- Karthik
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.ASA I and II
2.Patients undergoing elective nasal and oral surgical procedure under GA
3.Procedure duration of 60 - 240 minutes
Exclusion Criteria
1.Refusal by patient
2.ASA III and more
3.Patient on MAO inhibitors &Beta-adrenergic blocking drugs
4.Suspected allergy to a2 adrenergic agonist or NSAIDS
5.Patients with severe bradyarrhythmia secondary to AV block
6.Ischemic heart disease and valvular heart disease
7.Cognitive impairment
8.Psychiatric illness
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method